Establishment of a <scp>five‐enzalutamide‐resistance‐related‐gene‐based</scp> classifier for <scp>recurrence‐free</scp> survival predicting of prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer

Published:2022-09-28 Issue:21 Volume:26 Page:5379-5390
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Chen Jing¹,Meng Jialin¹^ORCID,Liu Yi¹,Bian Zichen¹,Niu Qingsong¹,Chen Junyi¹,Zhou Jun¹,Zhang Li¹,Zhang Meng¹²^ORCID,Liang Chaozhao¹^ORCID

Affiliation:

1. Department of Urology The First Affiliated Hospital of Anhui Medical University Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases Anhui Medical University Hefei Anhui China

2. Urology Institute of Shenzhen University The Third Affiliated Hospital of Shenzhen University Shenzhen University Shenzhen China

Funder

Natural Science Foundation of Guangdong Province

ASCRS Research Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17554

Reference42 articles.

1. Cancer statistics, 2019

2. Screening for Prostate Cancer

3. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

4. Prostate cancer

5. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP